AVR
Anteris TechnologiesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AVR
Anteris Technologies Global Corp.
A structured heart company dedicated to discovering, developing, and commercializing innovative medical devices
Life Science Tools and Services
01/29/2024
12/13/2024
NASDAQ Stock Exchange
136
12-31
Common stock
Toowong Tower, Level 3, Suite 302, 9 Sherwood Road, Toowong, QLD 4066, Australia
--
Anteris Technologies Global Corp. was incorporated in Delaware on January 29, 2024. The Company is a structural heart company dedicated to the discovery, development and commercialization of Innovative Medical devices designed to improve the quality of life of patients with aortic stenosis.
Company Financials
EPS
AVR has released its 2025 Q3 earnings. EPS was reported at -0.62, versus the expected -0.57, missing expectations. The chart below visualizes how AVR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AVR has released its 2025 Q3 earnings report, with revenue of 429.00K, reflecting a YoY change of -44.21%, and net profit of -22.21M, showing a YoY change of -1.90%. The Sankey diagram below clearly presents AVR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
